Cytoskeletal myotoxicity from simvastatin and colchicine

Muscle & Nerve
Steven K BakerMark A Tarnopolsky

Abstract

We report the case of a 79-year-old man with mild chronic renal failure who developed severe rhabdomyolysis after combined exposure to simvastatin and colchicine. Colchicine induces myopathy through disruption of microtubular function with subsequent vacuolization and pseudomyelinic body accumulation. Statin therapy is associated with myonecrosis, membranous myeloid bodies, and vacuolization, presumably as a function of impaired isoprenoid metabolism. Vesicle trafficking requires small G-protein prenylation and statins can disrupt cytoskeletal integrity. We propose that synergistic cytoskeletal myotoxicity may account for the extreme elevation of serum creatine kinase not previously reported in pure colchicine myopathy.

References

Jun 18, 1987·The New England Journal of Medicine·R W KunclM Peper
Mar 1, 1988·Archives of Neurology·R W Kuncl, G Duncan
May 1, 1986·Archives of Neurology·J E RiggsA G DiBartolomeo
Aug 1, 1966·Archives of Neurology·P SlotwinerP J Anderson
Jan 1, 1967·Journal of Neuropathology and Experimental Neurology·P J AndersonP Slotwiner
Sep 1, 1993·Journal of Neuropathology and Experimental Neurology·A J WaclawikA G Engel
Jul 1, 1993·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·S BoudriauP A Rogers
Jan 1, 1996·Annual Review of Biochemistry·F L Zhang, P J Casey
Oct 24, 1998·The American Journal of Emergency Medicine·S T Milne, P D Meek
Oct 14, 2000·Annual Review of Cell and Developmental Biology·K H Downing
Jan 12, 2001·Physiological Reviews·Y TakaiT Matozaki
Nov 1, 2002·Clinical Neuropharmacology·Wei-Chih HsuHou-Chang Chiu
Apr 23, 2003·Experimental Cell Research·Ralph W KunclRobert Adams
Jan 1, 1965·Archives of Internal Medicine·A A CARR
Jan 4, 1962·The New England Journal of Medicine·H A KONTOS

❮ Previous
Next ❯

Citations

Oct 5, 2011·Current Neurology and Neuroscience Reports·F L Mastaglia, M Needham
Feb 5, 2009·European Heart Journal·Massimo ImazioYehuda Adler
Jan 23, 2009·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Beatrice A Golomb, Marcella A Evans
Oct 7, 2009·Future Cardiology·Massimo ImazioYehuda Adler
Jul 20, 2014·Neurologic Clinics·Mamatha PasnoorMazen M Dimachkie
Apr 26, 2013·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Pornwalai BoonmuangPairin Supsongserm
Oct 7, 2006·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Hans-Jürgen GdyniaGeorg Haerter
Oct 9, 2007·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Maria JustinianoLuis R Espinoza
Aug 15, 2009·Current Opinion in Neurology·Ralph W Kuncl
May 26, 2009·Expert Opinion on Pharmacotherapy·Naomi SchlesingerFernando Perez-Ruiz
Nov 1, 2008·Seminars in Arthritis and Rheumatism·Robert A Terkeltaub
Aug 12, 2009·Muscle & Nerve·Agnes Supala-BergerEufrosina Young-McLain
Sep 29, 2012·Pharmacotherapy·Brittany A ToddTheresa M Wagner
Apr 18, 2007·The American Journal of Cardiology·David Demitry BoltanWilliam Clifford Roberts
Oct 28, 2006·Joint, Bone, Spine : Revue Du Rhumatisme·Elisabeth Niel, Jean-Michel Scherrmann
Nov 5, 2013·Autophagy·James K ChingConrad C Weihl
Jun 16, 2005·The Annals of Pharmacotherapy·Enes Murat AtasoyuEmrullah Solmazgul
Jun 15, 2006·The Annals of Pharmacotherapy·Abdurrahman TufanArzu Topeli
Aug 7, 2018·Current Opinion in Neurology·Mamatha PasnoorMazen M Dimachkie
Oct 19, 2016·Circulation·Barbara S WigginsUNKNOWN American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology; Council on Hypertension; C
Apr 8, 2020·Pharmacotherapy·Carly A Webb, Arden R Barry
Apr 3, 2008·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Steven K Baker, Imtiaz A Samjoo
Dec 23, 2017·Rheumatology·Anastasia SlobodnickMichael H Pillinger
Jun 28, 2019·Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders·Marcos Edgar Fernández-CuadrosOlga Susana Pérez-Moro
Jan 5, 2017·Journal of Medical Case Reports·Clara FrydrychowiczLorenz Weidhase
May 26, 2018·Pharmaceuticals·Andreas Jordan, Ursula Gresser
Aug 26, 2020·Current Neurology and Neuroscience Reports·Elena Crisan, Vijaya K Patil
Jan 20, 2021·Heart, Lung & Circulation·Rahul KurupSanjay Patel
Nov 7, 2018·Clinical Therapeutics·Aernoud T L FioletJan H Cornel
May 25, 2021·CEN Case Reports·Nikolaos SabanisGeorgios Zagkotsis
Jul 23, 2021·BMJ Case Reports·Mohammad AbudalouAli Al Sbihi
Jul 29, 2021·Zeitschrift für Orthopädie und Unfallchirurgie·Jürgen Steinmeyer, Johannes Flechtenmacher

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.